3 ms·
"open-source", IP-free anticancer drug candidate (http://indysci.org http://indysci.org) We're launching in January (or possibly December) It's cool, because
by dnautics 13y ago
"open-source", IP-free anticancer drug candidate (http://indysci.org http://indysci.org)
We're launching in January (or possibly December)
It's cool, because we want to disrupt the way that pharma operates. Biotech could learn a lot from the way that the software industry has been revolutionized by the open-source philosophy. The world could stand to also see tangible benefits if we succeed in (re)proving it's actually possible. People have done this in the past (salk and sabin come to mind); sometimes the global consciousness just needs a reminder.
- mtdewcmu 13y agoGreat cause. Why is industry not interested in developing 9-deoxysibiromycin as a drug?
- dnautics 13y agounpatentable. Check the date: https://www.ncbi.nlm.nih.gov/pubmed/22390171 https://www.ncbi.nlm.nih.gov/pubmed/22390171 Also the mechanism of action is baroque (although the compound class has fewer side effects), standard pharma is mostly interested in flashy new types of anticancer mechanisms.
- jnbiche 13y agoThank you and awesome! Although I've seen some great projects scrolling down, this is the first that has elicited a comment. I wish you all the best in your attempt to disrupt pharma -- it needs it.
- dnautics 13y agoThanks, I'm going to need a lot of luck! We're asking for a lot of money to give a level of security that this will work out (the balance of the funds at the end of the research term will be disbursed to city of hope - a hospital with a cancer treatment specialization). So there's the trickiness of fundraising, and figuring out the internet. The internet is a hard place. On top of that, science is always risky, and as much as I can craft a plan B and a plan C, and dynamically come up with plans, there's always the possibility of total failure.